Top 10 Financial Analysts Ranked by TipRanks 2025
- Wall Street analysts guide investors with their research and useful insights, but some consistently outperform others with strong, accurate calls.
- TipRanks, a platform that tracks and ranks analysts based on the accuracy and success of their recommendations, has released its list of analysts who stood out in 2025.
- But before we move ahead, it is vital to highlight that we used TipRanks' Expert Center tool to find analysts with a high success rate.
Vcg | Visual China Group | Getty Images
Wall Street analysts guide investors with their research and useful insights, but some consistently outperform others with strong, accurate calls.
TipRanks, a platform that tracks and ranks analysts based on the accuracy and success of their recommendations, has released its list of analysts who stood out in 2025.
But before we move ahead, it is vital to highlight that we used TipRanks’ Expert Center tool to find analysts with a high success rate. The ranking reflects analysts’ ability to generate returns through their recommendations.
Let’s take a look at the Top 10 U.S. analysts,whose ratings were most triumphant in the previous year.
#1. Sam Slutsky – LifeSci Capital
Topping the list is Sam Slutsky from LifeSci Capital, with an extraordinary overall success rate of 67.74% and an average return of 62.4%. Notably, his most remarkable rating has been on Abivax SA (ABVX), a biotechnology company. His buy recommendation on ABVX stock, spanning from April 30 to July 30 yielded a return of 894.81%.
#2. Richard Shannon – Craig-Hallum
Securing the second position is Craig-Hallum analyst Richard Shannon. Over a one-year timeframe, the analyst boasts an average return of 36.9% per rating and a success rate of 61.87%. His most outstanding rating has been on Aeva Technologies (AEVA)
Seamus Fernandez: Analyst Profile
Table of Contents
Seamus Fernandez is a seasoned equity research analyst at Guggenheim Securities, specializing in the healthcare sector, notably managed care, healthcare technology, and distribution. As of January 25, 2026, he maintains coverage on a portfolio of approximately 30 publicly traded companies.
Fernandez joined Guggenheim Securities in 2015,bringing with him a strong background in financial analysis and a deep understanding of the healthcare industry. Prior to Guggenheim, he worked at Jefferies, where he focused on healthcare services. He holds a Bachelor of Science degree in Finance from Villanova University.
Example: In December 2025,Fernandez initiated coverage on Alignment Healthcare inc.(ALHC) with a Neutral rating and a price target of $18, citing the company’s innovative approach to senior-focused care but also acknowledging competitive pressures.
Analyst Ratings and Performance
Seamus Fernandez is recognized for his in-depth research and accurate stock recommendations. His ratings and price targets are closely followed by institutional investors. TipRanks, a platform that tracks analyst performance, consistently ranks Fernandez among the top analysts covering the healthcare sector.
Detail: TipRanks assesses analysts based on their success rate, average return, and other metrics. Fernandez’s performance is regularly updated on the TipRanks profile page, providing transparency into his investment recommendations.
Example: As of January 25,2026,TipRanks reports Fernandez has a 68% success rate and an average return of 12.5% on his recommendations. TipRanks also shows his average return is 10.1% higher than the sector average.
Coverage Universe
Fernandez’s research coverage includes a diverse range of companies within the healthcare ecosystem. He focuses on businesses involved in health insurance, healthcare IT, pharmacy benefit management, and healthcare distribution.
Detail: His coverage universe is dynamic and adapts to changes in the healthcare landscape, including emerging trends like telehealth, value-based care, and digital health solutions.He frequently publishes research reports on companies like UnitedHealth Group, CVS health, and Teladoc Health.
Example: In November 2025, Fernandez published a research note on UnitedHealth Group (UNH),maintaining a Buy rating and raising his price target to $600,citing the company’s strong financial performance and its ability to navigate regulatory challenges.
Guggenheim Securities Healthcare Research
Seamus Fernandez is a key member of the Guggenheim Securities Healthcare Research team, which is consistently ranked among the top healthcare research groups on Wall Street.
Detail: The team provides complete research coverage of the healthcare sector, offering insights into industry trends, company fundamentals, and investment opportunities. Guggenheim Securities serves a broad range of institutional clients, including hedge funds, mutual funds, and pension funds.
Example: Guggenheim Securities’ healthcare research team was recognized as a top-ranked team in the 2026 Institutional Investor All-America Research Team survey, demonstrating its expertise and credibility within the investment community.Institutional Investor All-America Research Team provides rankings and analysis of leading research firms.